MYCN and neuroblastoma: Due to the epigenetic modulation, these agents offer an effective means to therapeutically alter the regulation of proto-oncogenes and tumor suppressor genes in malignant cells and induce pro-apoptotic transcriptional changes in MYCN amplified neuroblastoma cell lines [53,54].